Alpha Lipoic Acid for Burning Mouth NCT00387543

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Clinical Trial Details — Status: Completed

Study information
Verified date	April 2011
Source	Mayo Clinic
Contact	n/a
Is FDA regulated	No
Health authority	United States: Institutional Review Board
Study type	Observational

Discussion and evaluation of patients with sore and burning mouth to determine whether alpha lipoic acid is helpful in managing their symptoms.

Recruitment information / eligibility
Status	Completed
Enrollment	200
Est. completion date	July 2007
Est. primary completion date	July 2007
Accepts healthy volunteers	No
Gender	Both
Age group	1 Year and older
Eligibility	Patients seen in the Department of Dermatology with diagnosis of burning mouth syndrome between 2000 and 2005

Time Perspective: Retrospective

Locations
Country	Name	City	State
United States	Mayo Clinic	Rochester	Minnesota

Sponsors *(1)*
Lead Sponsor	Collaborator
Mayo Clinic

United States,